Industry News

Stock Alert

[December 11, 2007] PSMH, SYBD, SLNH, AUCI - Stock Alert

(M2 PressWIRE Via Thomson Dialog NewsEdge)

Rochester, NY --'s "Mid-Day Stock Watch Alert"
this afternoon are PSM Holdings, Inc. (Pink Sheets: PSMH), Synthetic
Blood International, Inc. (OTCBB: SYBD), Splinternet Holdings, Inc.
(OTCBB: SLNH), Auctions International Inc. (Pink Sheets: AUCI).

Sign-up for our FREE Stock Alerts at !

PSM Holdings, Inc. (Pink Sheets: PSMH - ) (Mon, December 10, 2007, 4:55pm
ET) PrimeSource Mortgage, Inc. (PSMI) continues to open branches
Nationwide. PSMI proudly announces the opening of an independently
owned and operated PrimeSource Mortgage (PSM) office in Clovis, New
Mexico. Rebecca Reid-Carlyle is the owner and operator of this new PSM

Carlyle comes with a great reputation in the business community of
Clovis. She was highly recommended by one of our existing branch
operations. We are very excited to have her "re-open" the Clovis market
for PrimeSource. PrimeSource was a part of the Clovis community for
close to 10 years, and now Rebecca will be bringing the unique,
unsurpassed customer service concept of PrimeSource Mortgage's "We Walk
You Home" spirit back to Curry County.

Carlyle believes there are many advantages to being a part of the
PrimeSource family. With the backing of a larger company with programs
to put her above the competition, such as the NWBO platforms and PushMX
Software, PSMI is also licensed in 25 states which expands her outreach.

Incorporated in 1991 in Texas, PrimeSource Mortgage, Inc. quickly
became a leading mortgage company in the Southwest and is currently
licensed in 25 states. One reason for the growth and success of this
company is its commitment to personalized customer service embodied in
the motto: We Walk You Home. Because the mortgage process is so complex
and often confusing, the company has chosen to walk hand-in-hand with
each client through the entire process.

PSM Holdings, Inc. (Pink Sheets: PSMH - News), the parent company, is
now a publicly traded company; over-the-counter (OTC) shares became
available in October 2005. Ron Hanna, Chairman of the Board, said, "We
are excited about this because it offers our customers and staff the
opportunity to own a part of our company."

For more information about PSMH, go to its Web site at

Synthetic Blood International, Inc. (OTCBB: SYBD - ) (Tue, December 11, 2007, 4:00am
ET) Synthetic Blood International, Inc. today announced its plan to
finalize a Phase IIb clinical trial protocol with Oxycyte for the
treatment of traumatic brain injury (TBI) at its Scientific Advisory
Board (SAB) meeting scheduled for Thursday, December 13, 2007. Oxycyte
is Synthetic Blood's proprietary perfluorocarbon (PFC) therapeutic
oxygen carrier and blood substitute.

The proposed double blind, placebo-controlled Phase IIb trial is
designed to compare Oxycyte with present-day advanced therapies in TBI,
and is expected to enroll 120 to 150 patients at six major neurosurgery
centers. The trial protocol was prepared by M. Ross Bullock, M.D.,
Ph.D., of the University of Miami Miller School of Medicine, Department
of Neurosurgery. Dr. Bullock was a principal investigator on Synthetic
Blood's Phase IIa pilot study with Oxycyte in TBI and currently serves
on the Company's SAB.

Synthetic Blood also announced intentions to name additional members to
its SAB at the December 13 meeting. Those candidates under review are
primarily located at medical centers that may be involved with Oxycyte
trials. Additionally, the SAB plans to develop a strategy for
initiating supportive preclinical studies to explore the basic science
of Oxycyte's oxygen delivery capabilities for the treatment of damaged
brain tissue, and the effects of higher Oxycyte doses than have been
used in previous studies, as well as the potential effects of
administering second doses of Oxycyte.

"Our Phase IIb trial protocol design was developed to provide what we
believe will be definitive results with Oxycyte as a therapeutic
treatment for TBI," stated Dr. Bullock. "Positive data from the pilot
study in TBI patients demonstrated that Oxycyte was more effective in
increasing brain oxygen tension levels and impacting other brain
chemistries that contribute to favorable clinical outcomes in TBI
patients than breathing either 100 percent or 50 percent oxygen. If we
see similar results in the larger patient population, we believe that
it is likely that the government may deem Oxycyte immediately useful
for battlefield settings."

"We are making headway in our development program with Oxycyte in TBI
that will capitalize on the favorable results from our Phase IIa pilot
study," said Robert Larsen, Interim President and CEO of Synthetic
Blood. "Finalizing the protocol is an important step in the process to
prepare for our Phase IIb trial protocol submission to the U.S. Food
and Drug Administration."

Splinternet Holdings, Inc. (OTCBB: SLNH - ) (Tue, December 11, 2007, 9:27am
ET) Splinternet Holdings, Inc. announced that it is entering the
anti-terrorism market with a new radiation detection device and
monitoring system which will provide early warning of the presence of
radioactive materials of the type feared to be usable in dirty bombs.

Together with its development of a networked radiation detection
device, Splinternet has entered into a cross-licensing and selling
agreement with privately-held Vidiation, LLC, a development-stage
company with a revolutionary technology to identify radioactive
materials by analyzing streams of data from video surveillance systems.
Vidiation launched its Vidiation-Radiation Analytics Detection System
or V-RADS at the Fall 2007 ASIS conference, and plans to enter the
market shortly. ( Vidiation is the developer of a
software-based technology that detects the presence of radiation when
it comes in range of a video surveillance camera. The gamma rays from
threats such as "dirty bombs" strike an image sensor in the camera
causing a detectable pattern of interference. As the data from the
camera is examined by Vidiation's V-RADS software, this radiation
pattern is detected and an ALERT is sent to the designated monitoring
station. This is strictly a software solution, which doesn't require
modification to the cameras.

The Splinternet device is more sensitive than the software/video camera
solution, but it does not provide a video image of the monitored site,
as the Vidiation system does. The two systems are wholly compatible and

Vidiation's software solution dovetails with Splinternet's existing
VoIP infrastructure, and requires no additional commitment of capital
or retrofitting of Splinternet's existing network. By leveraging its
VoIP expertise, Splinternet has developed a small hardware-based
radiation detection device to work in conjunction with Vidiation's
software by functioning as a smart networked radiation detection node.
Like Splinternet's VoIP solution, the combined Splinternet/Vidiation
products will network using Ethernet technology and will be managed via
a local LAN or the World Wide Web.

Splinternet's President, James Ackerly said, "Splinternet and Vidiation
have each developed ways to monitor large areas for the existence of
gamma ray-emitting substances, and the realization that our two
techniques are helpful to each other, rather than competitive has led
us to the new business arrangement we are announcing today. We are
pleased to enter the 'War on Terrorism' in this way, as the
availability of wide area detection systems will serve as a deterrent
to those who would hope to sneak a dirty bomb into an economically or
politically strategic location. We have been attracted to the
anti-terrorism space for some time and believe that with Vidiation we
have a compelling entry into the market. We believe there is
significant demand worldwide for this service, which offers customers a
new layer of protection from improper transport of high energy

Ackerly continued, "We have tested the prototype combined system in
real-world medical facilities and are pleased with the results. We will
work with Vidiation toward achieving government validation, which we
expect will be realized in early 2Q08, at which time we plan to begin
aggressively selling the systems. In fact, the US Government has
budgeted over $1 billion in 2007 for radiation detection systems, but
it is reported that they are dissatisfied with the existing solutions.
We believe our combined offering will have a significant impact in the
radiation detection market. We are excited about this new product
offering and plan to continue our strategy of targeting partnerships
and acquisitions with innovative product offerings that can leverage
our management and our network expertise."

Auctions International Inc. (Pink Sheets: AUCI - ) (Tue, December 11, 2007, 7:00am
ET) Auctions International Inc., a technology company that owns and
markets proprietary software to enable real time online auctions of
virtually any product or commodity for use by the wholesale market,
issued a statement from President and CEO Doug Mann regarding
yesterday's volume and price change in its common stock, "No material
changes in the Company or management would warrant an increase in
trading volume or the sudden drop in share price that occurred on
December 10th."

Mann explains, "The selling pressure may have been caused by a
confusion between our Company and, with whom we have
no affiliation. Coincidentally, is also in the
auctions business and trades on the pink sheets under the stock symbol
AUCC, just one letter off from ours. indicated it
would effect a 1-for-1000 reverse split on yesterday, and
that this split would be effective today. We want to clarify we are
unrelated companies to those who may have mistaken us for this company.

"Management would like to ensure shareholders that Auctions
International Inc. is moving in a very positive direction. With our
technology model, AUCI lets people sell, buy and advertise in real-time
to close transactions quickly to take advantage of economic conditions,
particularly the strong Canadian dollar, which is opening up new
business opportunities in the U.S. Auctions International has completed
extensive dealer testing of AutoBidLive and is now ready to take every
dealer in North America live on the system. 2007 marked our entry into
the commercialization phase of our technology platform, and management
is very optimistic that 2008 will be a tremendous year of growth and
increased shareholder value."

About (OTCS) is a leading investor relations firm whose
primary focus is promoting awareness among brokers, investors, and
others in the investment community who are interested in small and
micro-cap companies. OTCS is dedicated to helping publicly traded
companies gain the exposure they need to move forward with the
development of their business plans. OTCS's goal is to feature equity
investments in micro or small capitalization companies that have the
potential for long-term appreciation. OTCS provides all investors with
the latest news, press releases, investment opinions, and research
reports for all the companies highlighted on the site. OTCS offers a
free financial newsletter. To subscribe or get more information, visit
our home page located at .

We offer many investor relations programs to public companies. To
feature a company on our web site or in our daily Newsletter or Mid-Day
Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via
email at .

OTCS's affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event of a rise in value. OTCS will not advise as to when it
decides to sell and does not and will not offer any opinion as to when
others should sell; each investor must make that decision based on his
or her judgment of the market. (OTCS) based upon information believed to be
reliable herein prepared all material. The information contained herein
is not guaranteed by OTCS to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. OTCS is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned
herein. OTCS has been compensated by third party shareholders or with
cash from the company on behalf of one or more of the companies
mentioned in this opinion.

This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission. You should
consider these factors in evaluating the forward-looking statements
included herein, and not place undue reliance on such statements. The
forward-looking statements in this release are made as of the date
hereof and OTCS undertakes no obligation to update such statements.

CONTACT: Chris Wheeler,
Tel: +1 585 330 8514

((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to

Copyright 2007 M2 Communications Ltd.

[ Back To Contact Center Solutions's Homepage ]